Lenalidomide Capsule bulk supplier for pharma manufacturers

Lenalidomide Capsule Suppliers & Bulk Manufacturers

Available Forms: Oral Capsules

Available Strengths: 2.5 mg, 5 mg, 10 mg, 15 mg, 25 mg

Reference Brands: Revlimid® (EU & US)

Lenalidomide (brand name Revlimid®) is an immunomodulatory drug used to treat multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL). Available in oral capsules with strengths ranging from 2.5 mg to 25 mg, it enhances the immune system and inhibits tumor growth. Sourced by B2B pharmaceutical wholesalers in the US and EU, Lenalidomide ensures a reliable supply of GMP-compliant medications, offering competitive pricing for oncology centers and cancer treatments.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Lenalidomide is an immunomodulatory drug (IMiD) used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL). Available under the brand Revlimid® by Bristol Myers Squibb, it is offered in oral capsule form in strengths ranging from 2.5 mg to 25 mg. Lenalidomide works by enhancing the immune system and inhibiting tumor cell growth. Widely sourced by B2B pharmaceutical wholesalers in the US and EU, it ensures reliable supply of high-quality, GMP-compliant medications for oncology centers, providing competitive pricing for cancer treatments.

Lenalidomide Capsule — third party manufacturing & bulk supply

Lenalidomide Capsule is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lenalidomide Capsule is supplied as Oral Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lenalidomide Capsule listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lenalidomide Capsule →

Back to Listing

Frequently Asked Questions

Lenalidomide is used in the treatment of certain hematological cancers, primarily multiple myeloma. It is also indicated for myelodysplastic syndromes (MDS) associated with deletion 5q, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma, either alone or in combination with other anticancer agents, depending on the indication and treatment protocol.

Lenalidomide is a synthetic immunomodulatory agent derived from thalidomide. It is chemically manufactured and designed to enhance immune function, inhibit tumor cell proliferation, and suppress angiogenesis.

Lenalidomide is globally marketed under the trade name Revlimid.

The original branded product Revlimid was developed and marketed by Celgene Corporation, which is now a part of Bristol Myers Squibb. Generic versions are manufactured by several approved pharmaceutical companies in different regions.

The complete generic name is lenalidomide.

The brand name of lenalidomide is Revlimid, along with various approved generic brands available in different countries.

Lenalidomide is manufactured in multiple countries including the United States, European Union countries, India, and other regulated pharmaceutical manufacturing regions, depending on the brand and manufacturer.